

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to ethanol (GO:0071361) | 4.78430783 |
| 2 | macroautophagy (GO:0016236) | 4.49475745 |
| 3 | phospholipid homeostasis (GO:0055091) | 4.31696458 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 4.30544511 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.12115114 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.12115114 |
| 7 | urea cycle (GO:0000050) | 3.98241778 |
| 8 | urea metabolic process (GO:0019627) | 3.98241778 |
| 9 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95278524 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 3.91175560 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91175560 |
| 12 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.82468707 |
| 13 | lysine catabolic process (GO:0006554) | 3.80205841 |
| 14 | lysine metabolic process (GO:0006553) | 3.80205841 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.76650825 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 3.76650825 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.69848695 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.67417380 |
| 19 | peptide catabolic process (GO:0043171) | 3.67183013 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.63744417 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.62694061 |
| 22 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.53867935 |
| 23 | histone H3-K36 demethylation (GO:0070544) | 3.45342583 |
| 24 | nuclear pore complex assembly (GO:0051292) | 3.44279503 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 3.43887925 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.42065379 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 3.38626683 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34013128 |
| 29 | protein carboxylation (GO:0018214) | 3.34013128 |
| 30 | lipid translocation (GO:0034204) | 3.28647490 |
| 31 | phospholipid translocation (GO:0045332) | 3.28647490 |
| 32 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.25627936 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.24402997 |
| 34 | homocysteine metabolic process (GO:0050667) | 3.23791339 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 3.21457017 |
| 36 | complement activation, alternative pathway (GO:0006957) | 3.21284826 |
| 37 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.20261496 |
| 38 | regulation of cholesterol storage (GO:0010885) | 3.14490050 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.14315544 |
| 40 | positive regulation of glycolytic process (GO:0045821) | 3.13486677 |
| 41 | cysteine metabolic process (GO:0006534) | 3.11531638 |
| 42 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10456337 |
| 43 | glycoprotein catabolic process (GO:0006516) | 3.09683179 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.08388331 |
| 45 | regulation of protein activation cascade (GO:2000257) | 3.07124799 |
| 46 | Rap protein signal transduction (GO:0032486) | 3.06550497 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05196537 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.05138341 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.03486275 |
| 50 | low-density lipoprotein particle clearance (GO:0034383) | 3.00609084 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.00422378 |
| 52 | response to peptidoglycan (GO:0032494) | 2.99135099 |
| 53 | lipoprotein transport (GO:0042953) | 2.98867821 |
| 54 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.98444865 |
| 55 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.97884856 |
| 56 | vesicle coating (GO:0006901) | 2.97636523 |
| 57 | phospholipid scrambling (GO:0017121) | 2.96907166 |
| 58 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.96100186 |
| 59 | apoptotic cell clearance (GO:0043277) | 2.95425471 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94514109 |
| 61 | peptidyl-lysine dimethylation (GO:0018027) | 2.94513046 |
| 62 | regulation of complement activation (GO:0030449) | 2.93851130 |
| 63 | nuclear pore organization (GO:0006999) | 2.92793044 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 2.92723055 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 2.91314286 |
| 66 | bile acid biosynthetic process (GO:0006699) | 2.90354458 |
| 67 | tricarboxylic acid metabolic process (GO:0072350) | 2.89028027 |
| 68 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.88452296 |
| 69 | phospholipid efflux (GO:0033700) | 2.88193439 |
| 70 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.87828909 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.85939493 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.83165021 |
| 73 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.83165021 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.83165021 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 2.83165021 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.83165021 |
| 77 | modulation by symbiont of host defense response (GO:0052031) | 2.83165021 |
| 78 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.82033488 |
| 79 | cholesterol efflux (GO:0033344) | 2.81920521 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.81553752 |
| 81 | tryptophan metabolic process (GO:0006568) | 2.81459693 |
| 82 | positive regulation of developmental pigmentation (GO:0048087) | 2.80461589 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 2.79041213 |
| 84 | negative regulation of sterol transport (GO:0032372) | 2.79041213 |
| 85 | glutamate metabolic process (GO:0006536) | 2.77474370 |
| 86 | midgut development (GO:0007494) | 2.76516263 |
| 87 | positive regulation of histone deacetylation (GO:0031065) | 2.74787368 |
| 88 | COPII vesicle coating (GO:0048208) | 2.74611257 |
| 89 | bile acid metabolic process (GO:0008206) | 2.73532861 |
| 90 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.72535484 |
| 91 | lipoprotein metabolic process (GO:0042157) | 2.71983837 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.71581466 |
| 93 | indole-containing compound catabolic process (GO:0042436) | 2.71215514 |
| 94 | indolalkylamine catabolic process (GO:0046218) | 2.71215514 |
| 95 | tryptophan catabolic process (GO:0006569) | 2.71215514 |
| 96 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71016614 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 2.69516554 |
| 98 | protein-lipid complex assembly (GO:0065005) | 2.68331551 |
| 99 | histone H3-K9 demethylation (GO:0033169) | 2.68121135 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 2.67361124 |
| 101 | regulation of fatty acid oxidation (GO:0046320) | 2.65784307 |
| 102 | alanine transport (GO:0032328) | 2.65500965 |
| 103 | NLS-bearing protein import into nucleus (GO:0006607) | 2.64538902 |
| 104 | regulation of membrane lipid distribution (GO:0097035) | 2.64032906 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 2.63926402 |
| 106 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.63772059 |
| 107 | plasma lipoprotein particle assembly (GO:0034377) | 2.62095294 |
| 108 | tyrosine metabolic process (GO:0006570) | 2.60077951 |
| 109 | regulation of fibrinolysis (GO:0051917) | 2.59645923 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.58949533 |
| 111 | pore complex assembly (GO:0046931) | 2.58761249 |
| 112 | cellular ketone body metabolic process (GO:0046950) | 2.58297450 |
| 113 | carnitine metabolic process (GO:0009437) | 2.57451352 |
| 114 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.57367611 |
| 115 | response to muramyl dipeptide (GO:0032495) | 2.55563834 |
| 116 | valine metabolic process (GO:0006573) | 2.55470254 |
| 117 | positive regulation of leukocyte degranulation (GO:0043302) | 2.55427676 |
| 118 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.54997682 |
| 119 | regulation of macrophage chemotaxis (GO:0010758) | 2.54766531 |
| 120 | N-glycan processing (GO:0006491) | 2.54305594 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 2.53849356 |
| 122 | nerve growth factor signaling pathway (GO:0038180) | 2.53753275 |
| 123 | plasma lipoprotein particle remodeling (GO:0034369) | 2.53483774 |
| 124 | protein-lipid complex remodeling (GO:0034368) | 2.53483774 |
| 125 | macromolecular complex remodeling (GO:0034367) | 2.53483774 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53298187 |
| 127 | drug catabolic process (GO:0042737) | 2.52721231 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 2.50627061 |
| 129 | regulation of triglyceride catabolic process (GO:0010896) | 2.50327476 |
| 130 | fatty acid transmembrane transport (GO:1902001) | 2.50101174 |
| 131 | Golgi to endosome transport (GO:0006895) | 2.49289141 |
| 132 | triglyceride homeostasis (GO:0070328) | 2.48268047 |
| 133 | acylglycerol homeostasis (GO:0055090) | 2.48268047 |
| 134 | I-kappaB phosphorylation (GO:0007252) | 2.48091372 |
| 135 | mannose metabolic process (GO:0006013) | 2.46940374 |
| 136 | iron ion import (GO:0097286) | 2.46828555 |
| 137 | protein targeting to vacuole (GO:0006623) | 2.46726026 |
| 138 | protein targeting to lysosome (GO:0006622) | 2.46726026 |
| 139 | establishment of protein localization to vacuole (GO:0072666) | 2.46726026 |
| 140 | serine family amino acid catabolic process (GO:0009071) | 2.46511963 |
| 141 | regulation of pigment cell differentiation (GO:0050932) | 2.46483552 |
| 142 | histone lysine demethylation (GO:0070076) | 2.45718580 |
| 143 | 4-hydroxyproline metabolic process (GO:0019471) | 2.45675632 |
| 144 | regulation of lipid catabolic process (GO:0050994) | 2.45195172 |
| 145 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44960859 |
| 146 | regulation of protein polyubiquitination (GO:1902914) | 2.44704562 |
| 147 | regulation of mononuclear cell migration (GO:0071675) | 2.43155612 |
| 148 | positive regulation of nuclease activity (GO:0032075) | 2.42307855 |
| 149 | positive regulation of interferon-alpha production (GO:0032727) | 2.41236500 |
| 150 | fatty acid oxidation (GO:0019395) | 2.41070473 |
| 151 | fatty acid homeostasis (GO:0055089) | 2.40602445 |
| 152 | interkinetic nuclear migration (GO:0022027) | 2.40004831 |
| 153 | cellular extravasation (GO:0045123) | 2.39760364 |
| 154 | regulation of B cell differentiation (GO:0045577) | 2.39663737 |
| 155 | intracellular lipid transport (GO:0032365) | 2.39352955 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.38526922 |
| 157 | protein prenylation (GO:0018342) | 2.37750031 |
| 158 | prenylation (GO:0097354) | 2.37750031 |
| 159 | histone demethylation (GO:0016577) | 2.37369465 |
| 160 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.37273371 |
| 161 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.34756325 |
| 162 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.33787702 |
| 163 | positive regulation of B cell differentiation (GO:0045579) | 2.32641648 |
| 164 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.31898469 |
| 165 | early endosome to late endosome transport (GO:0045022) | 2.29130282 |
| 166 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.29050553 |
| 167 | gastrulation with mouth forming second (GO:0001702) | 2.27945798 |
| 168 | positive regulation of chemokine secretion (GO:0090197) | 2.27714931 |
| 169 | B cell homeostasis (GO:0001782) | 2.26843324 |
| 170 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.25407648 |
| 171 | histamine secretion (GO:0001821) | 2.25218370 |
| 172 | myelin assembly (GO:0032288) | 2.24943483 |
| 173 | cell adhesion mediated by integrin (GO:0033627) | 2.24171891 |
| 174 | determination of adult lifespan (GO:0008340) | 2.24091616 |
| 175 | B cell proliferation (GO:0042100) | 2.23082842 |
| 176 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22088820 |
| 177 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.21902986 |
| 178 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.20670888 |
| 179 | regulation of interferon-beta production (GO:0032648) | 2.20461089 |
| 180 | detection of other organism (GO:0098543) | 2.20303607 |
| 181 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.19205280 |
| 182 | N-acetylneuraminate metabolic process (GO:0006054) | 2.18987608 |
| 183 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.18402742 |
| 184 | germinal center formation (GO:0002467) | 2.18088750 |
| 185 | protein localization to endosome (GO:0036010) | 2.17752422 |
| 186 | regulation of Rac protein signal transduction (GO:0035020) | 2.14739469 |
| 187 | positive regulation of mast cell activation (GO:0033005) | 2.13816730 |
| 188 | definitive hemopoiesis (GO:0060216) | 2.13803232 |
| 189 | histone H3-K9 methylation (GO:0051567) | 2.12762905 |
| 190 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.12712706 |
| 191 | immunoglobulin mediated immune response (GO:0016064) | 2.12244732 |
| 192 | regulation of chemokine secretion (GO:0090196) | 2.11787846 |
| 193 | glycosphingolipid catabolic process (GO:0046479) | 2.11771035 |
| 194 | necroptotic process (GO:0070266) | 2.10828880 |
| 195 | phospholipid dephosphorylation (GO:0046839) | 2.10605297 |
| 196 | detection of external biotic stimulus (GO:0098581) | 2.09989930 |
| 197 | negative regulation of neurotransmitter transport (GO:0051589) | 2.09611481 |
| 198 | cellular response to exogenous dsRNA (GO:0071360) | 2.08867975 |
| 199 | histone H3-K4 trimethylation (GO:0080182) | 2.08686165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.79380435 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47594402 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.23508044 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.86742143 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.79239900 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51096523 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.88736540 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82247905 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.80787848 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.77503907 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.58347381 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.56795338 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56312477 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18044824 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11307621 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10559261 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08941430 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07655489 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97887604 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.97741863 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96843708 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93626425 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76830207 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76574731 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75373448 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74740899 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72870252 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71101964 |
| 29 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.70771692 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65114879 |
| 31 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.65025614 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61405484 |
| 33 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.60658652 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59491834 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59491834 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58709756 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56353933 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.56099703 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54492634 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52948343 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52626083 |
| 42 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.52518479 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52491580 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50802207 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47387682 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44015047 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42290631 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41287652 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40482377 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38343373 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37294523 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37155982 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36004034 |
| 54 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34963788 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34434838 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34313848 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33015732 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32454833 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32300226 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30591980 |
| 61 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.30529491 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30474262 |
| 63 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29522326 |
| 64 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28773234 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28730083 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28335436 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27837255 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27704958 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27429244 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27412563 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25764354 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25504516 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24843067 |
| 74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24396257 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23967305 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23723821 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22946231 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22885735 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21645718 |
| 80 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.21203991 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19471257 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19467613 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18941079 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18778486 |
| 85 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.18602213 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18351568 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18043011 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16949960 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15959190 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15838858 |
| 91 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15593333 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15470009 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15042439 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14837283 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 1.13833423 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13582887 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13337746 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13309515 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.12395487 |
| 100 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12175759 |
| 101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12062126 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11726508 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11570157 |
| 104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11345954 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11207569 |
| 106 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11173444 |
| 107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10179061 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09937496 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09937496 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09590033 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09266994 |
| 112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09240289 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09186860 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08487689 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07891308 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07696289 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07326187 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06532098 |
| 119 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06329744 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04060225 |
| 121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03984839 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03731593 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03688739 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03479920 |
| 125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03478375 |
| 126 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03067798 |
| 127 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02874694 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02632676 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01732870 |
| 130 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01696605 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01224700 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00917978 |
| 133 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00904000 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00863884 |
| 135 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.00658709 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00519212 |
| 137 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99676878 |
| 138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99676878 |
| 139 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99516037 |
| 140 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.99495157 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98871516 |
| 142 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98599014 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97953659 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97570290 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96934485 |
| 146 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96829460 |
| 147 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96662405 |
| 148 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96374112 |
| 149 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95501618 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95389871 |
| 151 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94726291 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93784716 |
| 153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93130375 |
| 154 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91953156 |
| 155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91371776 |
| 156 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90239811 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90215586 |
| 158 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89689500 |
| 159 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89590634 |
| 160 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.88723876 |
| 161 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88378247 |
| 162 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88298001 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87948982 |
| 164 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87829833 |
| 165 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87332063 |
| 166 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87213755 |
| 167 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86576953 |
| 168 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86393298 |
| 169 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.85887545 |
| 170 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85328628 |
| 171 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85134463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.06878473 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.87238621 |
| 3 | MP0005360_urolithiasis | 4.66772841 |
| 4 | MP0005365_abnormal_bile_salt | 3.84515524 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.74320103 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.50363392 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.30897037 |
| 8 | MP0003252_abnormal_bile_duct | 3.06442909 |
| 9 | MP0002396_abnormal_hematopoietic_system | 3.01078439 |
| 10 | MP0008057_abnormal_DNA_replication | 2.94621104 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.71249010 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.71093414 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.69542145 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.69112072 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.64038181 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 2.63620748 |
| 17 | MP0002009_preneoplasia | 2.62286534 |
| 18 | MP0009840_abnormal_foam_cell | 2.49834384 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.33647518 |
| 20 | MP0003828_pulmonary_edema | 2.22832053 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.16495092 |
| 22 | MP0004130_abnormal_muscle_cell | 1.92760574 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.92590097 |
| 24 | MP0001790_abnormal_immune_system | 1.92491158 |
| 25 | MP0005387_immune_system_phenotype | 1.92491158 |
| 26 | MP0005083_abnormal_biliary_tract | 1.88913942 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.84992083 |
| 28 | MP0001800_abnormal_humoral_immune | 1.76062980 |
| 29 | MP0000383_abnormal_hair_follicle | 1.75091891 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.73167893 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.71578503 |
| 32 | MP0002419_abnormal_innate_immunity | 1.70370161 |
| 33 | MP0000609_abnormal_liver_physiology | 1.65295838 |
| 34 | MP0002405_respiratory_system_inflammati | 1.65133864 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.65023018 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.64888418 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.63105385 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.59793813 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.56428649 |
| 40 | MP0003724_increased_susceptibility_to | 1.55316984 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.51230385 |
| 42 | MP0005670_abnormal_white_adipose | 1.50867658 |
| 43 | MP0003195_calcinosis | 1.50435410 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.49984301 |
| 45 | MP0003436_decreased_susceptibility_to | 1.49976893 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.48376371 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.47172136 |
| 48 | MP0000685_abnormal_immune_system | 1.46648137 |
| 49 | MP0005332_abnormal_amino_acid | 1.46594998 |
| 50 | MP0005310_abnormal_salivary_gland | 1.46357876 |
| 51 | MP0000604_amyloidosis | 1.42648158 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.41682719 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.39072630 |
| 54 | MP0004947_skin_inflammation | 1.38858151 |
| 55 | MP0002723_abnormal_immune_serum | 1.38528341 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.33225612 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.30963120 |
| 58 | MP0003868_abnormal_feces_composition | 1.30782629 |
| 59 | MP0003448_altered_tumor_morphology | 1.29992161 |
| 60 | MP0005671_abnormal_response_to | 1.29755683 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.28724886 |
| 62 | MP0001819_abnormal_immune_cell | 1.27603850 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.26894886 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.23682868 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.21259099 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.20054415 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.19461629 |
| 68 | MP0006082_CNS_inflammation | 1.17358365 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.17069235 |
| 70 | MP0000371_diluted_coat_color | 1.16150431 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.16140194 |
| 72 | MP0002090_abnormal_vision | 1.16112117 |
| 73 | MP0009672_abnormal_birth_weight | 1.15799765 |
| 74 | MP0004233_abnormal_muscle_weight | 1.15496995 |
| 75 | MP0002006_tumorigenesis | 1.14024850 |
| 76 | MP0001756_abnormal_urination | 1.13192439 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.12201747 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.12004610 |
| 79 | MP0002928_abnormal_bile_duct | 1.11241182 |
| 80 | MP0003763_abnormal_thymus_physiology | 1.10221362 |
| 81 | MP0010307_abnormal_tumor_latency | 1.07956380 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 1.07449650 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.06509923 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.06340622 |
| 85 | MP0009697_abnormal_copulation | 1.05717657 |
| 86 | MP0008260_abnormal_autophagy | 1.05279870 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 1.05243734 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.04874351 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.03730012 |
| 90 | MP0005025_abnormal_response_to | 1.03485005 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.03431404 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.03431404 |
| 93 | MP0009785_altered_susceptibility_to | 1.02387749 |
| 94 | MP0002398_abnormal_bone_marrow | 1.02210674 |
| 95 | MP0005623_abnormal_meninges_morphology | 1.01411436 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.00676197 |
| 97 | MP0000598_abnormal_liver_morphology | 0.99031189 |
| 98 | MP0003690_abnormal_glial_cell | 0.98085190 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.97191747 |
| 100 | MP0000716_abnormal_immune_system | 0.96979094 |
| 101 | MP0005187_abnormal_penis_morphology | 0.92984499 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 0.92336547 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.91064809 |
| 104 | MP0003045_fibrosis | 0.90933627 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.89920514 |
| 106 | MP0005621_abnormal_cell_physiology | 0.89481303 |
| 107 | MP0001915_intracranial_hemorrhage | 0.89385975 |
| 108 | MP0003890_abnormal_embryonic-extraembry | 0.88758879 |
| 109 | MP0002722_abnormal_immune_system | 0.87347365 |
| 110 | MP0008004_abnormal_stomach_pH | 0.86226774 |
| 111 | MP0001849_ear_inflammation | 0.85166565 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.84209163 |
| 113 | MP0002269_muscular_atrophy | 0.83223501 |
| 114 | MP0002971_abnormal_brown_adipose | 0.83045109 |
| 115 | MP0003123_paternal_imprinting | 0.83013910 |
| 116 | MP0002168_other_aberrant_phenotype | 0.82745989 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.82579156 |
| 118 | MP0009053_abnormal_anal_canal | 0.82456827 |
| 119 | MP0010678_abnormal_skin_adnexa | 0.81957069 |
| 120 | MP0003283_abnormal_digestive_organ | 0.81157326 |
| 121 | MP0002254_reproductive_system_inflammat | 0.80965504 |
| 122 | MP0000538_abnormal_urinary_bladder | 0.80607523 |
| 123 | MP0000858_altered_metastatic_potential | 0.80583076 |
| 124 | MP0004883_abnormal_blood_vessel | 0.80498437 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80327912 |
| 126 | MP0004858_abnormal_nervous_system | 0.80068686 |
| 127 | MP0006054_spinal_hemorrhage | 0.79828864 |
| 128 | MP0002429_abnormal_blood_cell | 0.79624750 |
| 129 | MP0005334_abnormal_fat_pad | 0.79308556 |
| 130 | MP0003303_peritoneal_inflammation | 0.78986617 |
| 131 | MP0005408_hypopigmentation | 0.78120646 |
| 132 | MP0000516_abnormal_urinary_system | 0.77661944 |
| 133 | MP0005367_renal/urinary_system_phenotyp | 0.77661944 |
| 134 | MP0001853_heart_inflammation | 0.77568578 |
| 135 | MP0003632_abnormal_nervous_system | 0.77460972 |
| 136 | MP0003115_abnormal_respiratory_system | 0.77459577 |
| 137 | MP0005388_respiratory_system_phenotype | 0.76234782 |
| 138 | MP0002133_abnormal_respiratory_system | 0.76234782 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.75510687 |
| 140 | MP0003984_embryonic_growth_retardation | 0.74885805 |
| 141 | MP0002088_abnormal_embryonic_growth/wei | 0.72711279 |
| 142 | MP0005257_abnormal_intraocular_pressure | 0.72119887 |
| 143 | MP0000343_altered_response_to | 0.71983893 |
| 144 | MP0005275_abnormal_skin_tensile | 0.71731395 |
| 145 | MP0001661_extended_life_span | 0.71122825 |
| 146 | MP0003795_abnormal_bone_structure | 0.69917071 |
| 147 | MP0002837_dystrophic_cardiac_calcinosis | 0.69712390 |
| 148 | MP0008469_abnormal_protein_level | 0.69009952 |
| 149 | MP0005448_abnormal_energy_balance | 0.68635632 |
| 150 | MP0005384_cellular_phenotype | 0.66813056 |
| 151 | MP0004272_abnormal_basement_membrane | 0.66299230 |
| 152 | MP0002970_abnormal_white_adipose | 0.66278422 |
| 153 | MP0009703_decreased_birth_body | 0.66225476 |
| 154 | MP0001879_abnormal_lymphatic_vessel | 0.66096958 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.65115143 |
| 156 | MP0000427_abnormal_hair_cycle | 0.65033365 |
| 157 | MP0001324_abnormal_eye_pigmentation | 0.63763183 |
| 158 | MP0005535_abnormal_body_temperature | 0.62809945 |
| 159 | MP0003091_abnormal_cell_migration | 0.61399738 |
| 160 | MP0005248_abnormal_Harderian_gland | 0.60237682 |
| 161 | MP0002138_abnormal_hepatobiliary_system | 0.59795040 |
| 162 | MP0002697_abnormal_eye_size | 0.59529934 |
| 163 | MP0003806_abnormal_nucleotide_metabolis | 0.58266654 |
| 164 | MP0005220_abnormal_exocrine_pancreas | 0.57407061 |
| 165 | MP0004043_abnormal_pH_regulation | 0.57369755 |
| 166 | MP0009115_abnormal_fat_cell | 0.56690746 |
| 167 | MP0002086_abnormal_extraembryonic_tissu | 0.56221756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.99997906 |
| 2 | Complement deficiency (HP:0004431) | 3.57132793 |
| 3 | Papillary thyroid carcinoma (HP:0002895) | 3.43777967 |
| 4 | Xanthomatosis (HP:0000991) | 3.38843789 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.30398933 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.21635510 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07316350 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07316350 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07316350 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.06886133 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.04573794 |
| 12 | Ketosis (HP:0001946) | 3.01355214 |
| 13 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.98636339 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.97859025 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.97535875 |
| 16 | Epidermoid cyst (HP:0200040) | 2.93806996 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 2.89705707 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.86861821 |
| 19 | Global brain atrophy (HP:0002283) | 2.82808787 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 2.78457490 |
| 21 | Mitral stenosis (HP:0001718) | 2.75824313 |
| 22 | Skin nodule (HP:0200036) | 2.73893350 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73530677 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 2.71521848 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.67911959 |
| 26 | Gastrointestinal stroma tumor (HP:0100723) | 2.64595703 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.63554775 |
| 28 | Ketoacidosis (HP:0001993) | 2.61637343 |
| 29 | Long toe (HP:0010511) | 2.60035295 |
| 30 | Upper motor neuron abnormality (HP:0002127) | 2.59477062 |
| 31 | Spastic diplegia (HP:0001264) | 2.57065881 |
| 32 | Myocardial infarction (HP:0001658) | 2.56527299 |
| 33 | Colitis (HP:0002583) | 2.55586884 |
| 34 | Hypolipoproteinemia (HP:0010981) | 2.53970546 |
| 35 | Turricephaly (HP:0000262) | 2.52488528 |
| 36 | Recurrent sinusitis (HP:0011108) | 2.52333132 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.51167412 |
| 38 | Lymphangioma (HP:0100764) | 2.49428323 |
| 39 | Abnormality of complement system (HP:0005339) | 2.43998270 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.42462945 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.42292962 |
| 42 | Abnormality of the lower motor neuron (HP:0002366) | 2.41205954 |
| 43 | Macroorchidism (HP:0000053) | 2.39992367 |
| 44 | Thyroid carcinoma (HP:0002890) | 2.39407465 |
| 45 | Conjunctival telangiectasia (HP:0000524) | 2.35943037 |
| 46 | T lymphocytopenia (HP:0005403) | 2.35877268 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.34659109 |
| 48 | Viral hepatitis (HP:0006562) | 2.30928923 |
| 49 | Aneurysm (HP:0002617) | 2.30596790 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30302995 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.28470184 |
| 52 | Hypercholesterolemia (HP:0003124) | 2.27458845 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23950986 |
| 54 | Hyperammonemia (HP:0001987) | 2.23831598 |
| 55 | Thoracolumbar scoliosis (HP:0002944) | 2.23107244 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22067894 |
| 57 | Hyperglycinemia (HP:0002154) | 2.21173350 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 2.20832819 |
| 59 | Recurrent viral infections (HP:0004429) | 2.20736467 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.19619258 |
| 61 | Gingivitis (HP:0000230) | 2.18923915 |
| 62 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.18772277 |
| 63 | Absent/shortened dynein arms (HP:0200106) | 2.18772277 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.18080220 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.16696061 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.15794127 |
| 67 | Acute myeloid leukemia (HP:0004808) | 2.11936727 |
| 68 | Abnormality of the periventricular white matter (HP:0002518) | 2.10548805 |
| 69 | Subacute progressive viral hepatitis (HP:0006572) | 2.09163216 |
| 70 | Enlarged penis (HP:0000040) | 2.08957150 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.08813302 |
| 72 | Fatigue (HP:0012378) | 2.08769657 |
| 73 | Abnormality of the lumbar spine (HP:0100712) | 2.08444399 |
| 74 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.06347787 |
| 75 | Asymmetry of the thorax (HP:0001555) | 2.06168045 |
| 76 | Aortic aneurysm (HP:0004942) | 2.05864267 |
| 77 | Increased mean platelet volume (HP:0011877) | 2.05764029 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05675730 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05675730 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05675730 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04931014 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.04931014 |
| 83 | Retinal atrophy (HP:0001105) | 2.04619153 |
| 84 | Hand muscle atrophy (HP:0009130) | 2.03906812 |
| 85 | Hyperglycemia (HP:0003074) | 2.03003732 |
| 86 | Neonatal hypoglycemia (HP:0001998) | 2.01977985 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 2.01771402 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99219432 |
| 89 | Thickened calvaria (HP:0002684) | 1.99180485 |
| 90 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.98836040 |
| 91 | Widely spaced teeth (HP:0000687) | 1.97420539 |
| 92 | Dysostosis multiplex (HP:0000943) | 1.93993293 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.93872125 |
| 94 | Loss of speech (HP:0002371) | 1.93853685 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 1.93614446 |
| 96 | Buphthalmos (HP:0000557) | 1.92190950 |
| 97 | Recurrent skin infections (HP:0001581) | 1.91462197 |
| 98 | Esophageal varix (HP:0002040) | 1.90602180 |
| 99 | Portal hypertension (HP:0001409) | 1.90469369 |
| 100 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89946299 |
| 101 | Abnormality of glycine metabolism (HP:0010895) | 1.89946299 |
| 102 | Flat acetabular roof (HP:0003180) | 1.89747578 |
| 103 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.89689937 |
| 104 | Coarse hair (HP:0002208) | 1.87671577 |
| 105 | Hyperacusis (HP:0010780) | 1.87084488 |
| 106 | Curly hair (HP:0002212) | 1.87006684 |
| 107 | Thick nail (HP:0001805) | 1.86687868 |
| 108 | Short 4th metacarpal (HP:0010044) | 1.85186079 |
| 109 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.85186079 |
| 110 | Vasculitis (HP:0002633) | 1.84347850 |
| 111 | Bladder carcinoma (HP:0002862) | 1.83958537 |
| 112 | Bladder neoplasm (HP:0009725) | 1.83958537 |
| 113 | Axonal loss (HP:0003447) | 1.83934263 |
| 114 | Symptomatic seizures (HP:0011145) | 1.83600415 |
| 115 | IgA deficiency (HP:0002720) | 1.83531122 |
| 116 | Vertebral arch anomaly (HP:0008438) | 1.82916062 |
| 117 | Increased CSF protein (HP:0002922) | 1.82383258 |
| 118 | Absent frontal sinuses (HP:0002688) | 1.81843946 |
| 119 | Abnormality of the 4th metacarpal (HP:0010012) | 1.81672692 |
| 120 | Periodontitis (HP:0000704) | 1.81645617 |
| 121 | Abnormality of the prostate (HP:0008775) | 1.81414321 |
| 122 | Striae distensae (HP:0001065) | 1.81293512 |
| 123 | Renovascular hypertension (HP:0100817) | 1.80626251 |
| 124 | Prostate neoplasm (HP:0100787) | 1.79887965 |
| 125 | Mucosal telangiectasiae (HP:0100579) | 1.79139013 |
| 126 | Chronic hepatic failure (HP:0100626) | 1.78944571 |
| 127 | Inflammation of the large intestine (HP:0002037) | 1.78463765 |
| 128 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78274817 |
| 129 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78274817 |
| 130 | Gingival bleeding (HP:0000225) | 1.77921795 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.77873640 |
| 132 | Submucous cleft hard palate (HP:0000176) | 1.77820514 |
| 133 | Epistaxis (HP:0000421) | 1.77670480 |
| 134 | Disinhibition (HP:0000734) | 1.77410967 |
| 135 | Mediastinal lymphadenopathy (HP:0100721) | 1.75426847 |
| 136 | Upper limb amyotrophy (HP:0009129) | 1.74867099 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 1.74867099 |
| 138 | Death in childhood (HP:0003819) | 1.74736606 |
| 139 | Protruding tongue (HP:0010808) | 1.73782286 |
| 140 | Cortical dysplasia (HP:0002539) | 1.73525594 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.72951490 |
| 142 | Abnormality of the thoracic spine (HP:0100711) | 1.72738755 |
| 143 | Hyperglycinuria (HP:0003108) | 1.70605781 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67913844 |
| 145 | Limb hypertonia (HP:0002509) | 1.67482586 |
| 146 | Truncal obesity (HP:0001956) | 1.66784641 |
| 147 | Restrictive lung disease (HP:0002091) | 1.66118061 |
| 148 | Inappropriate behavior (HP:0000719) | 1.65883794 |
| 149 | Protuberant abdomen (HP:0001538) | 1.65860406 |
| 150 | Prolonged partial thromboplastin time (HP:0003645) | 1.65722731 |
| 151 | Hamartoma of the eye (HP:0010568) | 1.65315815 |
| 152 | Deep philtrum (HP:0002002) | 1.64924743 |
| 153 | Frequent falls (HP:0002359) | 1.64875907 |
| 154 | Spinal cord lesions (HP:0100561) | 1.64859560 |
| 155 | Syringomyelia (HP:0003396) | 1.64859560 |
| 156 | Elfin facies (HP:0004428) | 1.64315626 |
| 157 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.64308912 |
| 158 | Osteolytic defects of the hand bones (HP:0009699) | 1.64231208 |
| 159 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64231208 |
| 160 | Hydroxyprolinuria (HP:0003080) | 1.63974147 |
| 161 | Abnormality of proline metabolism (HP:0010907) | 1.63974147 |
| 162 | Menorrhagia (HP:0000132) | 1.63740856 |
| 163 | Hematochezia (HP:0002573) | 1.63400042 |
| 164 | Abnormality of the fingertips (HP:0001211) | 1.63066523 |
| 165 | Joint hemorrhage (HP:0005261) | 1.62294595 |
| 166 | Abnormality of nucleobase metabolism (HP:0010932) | 1.62183526 |
| 167 | Gastrointestinal inflammation (HP:0004386) | 1.62120464 |
| 168 | Relative macrocephaly (HP:0004482) | 1.61961992 |
| 169 | Asymmetric septal hypertrophy (HP:0001670) | 1.61853243 |
| 170 | Spondylolisthesis (HP:0003302) | 1.61537344 |
| 171 | Lymphopenia (HP:0001888) | 1.60833212 |
| 172 | Prolonged bleeding time (HP:0003010) | 1.60620094 |
| 173 | Abnormality of the hepatic vasculature (HP:0006707) | 1.60266425 |
| 174 | Pseudobulbar signs (HP:0002200) | 1.60205353 |
| 175 | Fair hair (HP:0002286) | 1.59687418 |
| 176 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.58850970 |
| 177 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.58850970 |
| 178 | Stomach cancer (HP:0012126) | 1.58023822 |
| 179 | Neurodegeneration (HP:0002180) | 1.57487469 |
| 180 | Recurrent bronchitis (HP:0002837) | 1.57009930 |
| 181 | Resting tremor (HP:0002322) | 1.56923346 |
| 182 | Heterotopia (HP:0002282) | 1.54900331 |
| 183 | Neoplasm of the heart (HP:0100544) | 1.54473888 |
| 184 | Gout (HP:0001997) | 1.53886857 |
| 185 | Fat malabsorption (HP:0002630) | 1.53703826 |
| 186 | Peripheral demyelination (HP:0011096) | 1.53621421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.62685461 |
| 2 | PKN2 | 3.16536829 |
| 3 | BLK | 3.15382615 |
| 4 | EIF2AK3 | 2.95764214 |
| 5 | MAP3K14 | 2.93334203 |
| 6 | PRKD3 | 2.69001136 |
| 7 | PTK6 | 2.52378734 |
| 8 | FRK | 2.42644218 |
| 9 | SIK1 | 2.37380065 |
| 10 | ERN1 | 2.33065776 |
| 11 | SCYL2 | 2.26041862 |
| 12 | CAMK1G | 2.18877414 |
| 13 | ACVR1B | 2.14915649 |
| 14 | PDGFRA | 2.02160512 |
| 15 | MAP3K10 | 2.01511959 |
| 16 | CAMK1D | 1.99264274 |
| 17 | RIPK1 | 1.93297176 |
| 18 | INSRR | 1.89810213 |
| 19 | LATS1 | 1.73310083 |
| 20 | IKBKE | 1.71880370 |
| 21 | RIPK4 | 1.69489923 |
| 22 | FGR | 1.65411537 |
| 23 | TTN | 1.64514520 |
| 24 | CDK12 | 1.63376426 |
| 25 | TAOK3 | 1.61658684 |
| 26 | NLK | 1.59086601 |
| 27 | FGFR4 | 1.57804743 |
| 28 | EEF2K | 1.56321560 |
| 29 | TEC | 1.52303746 |
| 30 | MAP3K13 | 1.49451903 |
| 31 | SGK3 | 1.41416344 |
| 32 | CSK | 1.39295125 |
| 33 | FGFR2 | 1.38982611 |
| 34 | MAP3K9 | 1.38476947 |
| 35 | KIT | 1.37492131 |
| 36 | NEK1 | 1.33770676 |
| 37 | PDK3 | 1.32682681 |
| 38 | PDK4 | 1.32682681 |
| 39 | MAP3K4 | 1.28317068 |
| 40 | KSR2 | 1.28062511 |
| 41 | YES1 | 1.26987030 |
| 42 | TNIK | 1.24324883 |
| 43 | BCKDK | 1.23171616 |
| 44 | CDK6 | 1.21137062 |
| 45 | BMPR2 | 1.15466121 |
| 46 | IRAK4 | 1.14585821 |
| 47 | RET | 1.13566722 |
| 48 | BTK | 1.13476879 |
| 49 | PRPF4B | 1.13289301 |
| 50 | CAMKK2 | 1.11741496 |
| 51 | MAP3K2 | 1.11425971 |
| 52 | PRKCH | 1.10626734 |
| 53 | STK38 | 1.09471868 |
| 54 | SGK2 | 1.05447816 |
| 55 | CAMKK1 | 1.05034755 |
| 56 | MAP4K1 | 1.04333936 |
| 57 | JAK1 | 1.03804231 |
| 58 | TRPM7 | 1.02949536 |
| 59 | DAPK2 | 1.02702184 |
| 60 | MATK | 1.01928618 |
| 61 | MTOR | 1.00700028 |
| 62 | ICK | 0.99671628 |
| 63 | ZAP70 | 0.98872333 |
| 64 | SIK2 | 0.98573438 |
| 65 | PTK2 | 0.98052350 |
| 66 | BRD4 | 0.97353499 |
| 67 | IRAK1 | 0.97098727 |
| 68 | LMTK2 | 0.96195041 |
| 69 | FER | 0.94818011 |
| 70 | PAK4 | 0.91291101 |
| 71 | TYK2 | 0.90524275 |
| 72 | IKBKB | 0.89880907 |
| 73 | FGFR3 | 0.89786981 |
| 74 | TGFBR2 | 0.89121266 |
| 75 | MKNK1 | 0.88702293 |
| 76 | ERBB3 | 0.87804228 |
| 77 | JAK3 | 0.86281356 |
| 78 | MELK | 0.85452267 |
| 79 | FGFR1 | 0.85389322 |
| 80 | EPHA3 | 0.85162929 |
| 81 | STK3 | 0.85036105 |
| 82 | SYK | 0.83458411 |
| 83 | NTRK3 | 0.83245361 |
| 84 | TBK1 | 0.81517647 |
| 85 | MKNK2 | 0.80589557 |
| 86 | PDGFRB | 0.80439087 |
| 87 | LYN | 0.78415350 |
| 88 | MAP2K4 | 0.76580780 |
| 89 | RPS6KA2 | 0.75547065 |
| 90 | TYRO3 | 0.75386623 |
| 91 | LRRK2 | 0.74525827 |
| 92 | JAK2 | 0.74025725 |
| 93 | HCK | 0.73997207 |
| 94 | PASK | 0.72061321 |
| 95 | MST4 | 0.70025022 |
| 96 | CHUK | 0.69659888 |
| 97 | PAK6 | 0.69167456 |
| 98 | LCK | 0.68306017 |
| 99 | STK24 | 0.67961467 |
| 100 | LATS2 | 0.67475002 |
| 101 | PDK2 | 0.67116196 |
| 102 | ERBB2 | 0.65938577 |
| 103 | FLT3 | 0.65766408 |
| 104 | PAK3 | 0.65523110 |
| 105 | DDR2 | 0.65340274 |
| 106 | PIM1 | 0.65011603 |
| 107 | NEK2 | 0.64370011 |
| 108 | ITK | 0.64011724 |
| 109 | PDK1 | 0.63415272 |
| 110 | EGFR | 0.62495367 |
| 111 | RPS6KA4 | 0.60373696 |
| 112 | ABL1 | 0.59535925 |
| 113 | NEK9 | 0.58691056 |
| 114 | SGK494 | 0.58446973 |
| 115 | SGK223 | 0.58446973 |
| 116 | ALK | 0.58077073 |
| 117 | CSF1R | 0.57557834 |
| 118 | MAP3K7 | 0.57556175 |
| 119 | FES | 0.57409514 |
| 120 | PRKAA1 | 0.56976453 |
| 121 | NTRK1 | 0.55670920 |
| 122 | GRK7 | 0.54285895 |
| 123 | WNK1 | 0.51911368 |
| 124 | STK38L | 0.48687343 |
| 125 | MAP2K1 | 0.47887934 |
| 126 | BMX | 0.47543869 |
| 127 | PRKAA2 | 0.47356215 |
| 128 | AKT3 | 0.47023813 |
| 129 | MAP3K8 | 0.46931379 |
| 130 | STK10 | 0.46486080 |
| 131 | ATM | 0.45977808 |
| 132 | PDPK1 | 0.45849320 |
| 133 | TXK | 0.45374866 |
| 134 | MARK3 | 0.44375695 |
| 135 | SGK1 | 0.44146426 |
| 136 | INSR | 0.43243982 |
| 137 | MAPK7 | 0.43161525 |
| 138 | CDK4 | 0.42937249 |
| 139 | TIE1 | 0.42877165 |
| 140 | CDC42BPA | 0.41159730 |
| 141 | IGF1R | 0.40058229 |
| 142 | MET | 0.40043390 |
| 143 | TGFBR1 | 0.39896378 |
| 144 | BRSK2 | 0.39661550 |
| 145 | DYRK1B | 0.39211581 |
| 146 | STK11 | 0.39043933 |
| 147 | PRKG2 | 0.38689182 |
| 148 | PTK2B | 0.38370553 |
| 149 | PRKD1 | 0.38071279 |
| 150 | MAPK11 | 0.37724444 |
| 151 | HIPK2 | 0.37724285 |
| 152 | CDK9 | 0.36720249 |
| 153 | PAK2 | 0.36624200 |
| 154 | BMPR1B | 0.35138642 |
| 155 | EIF2AK2 | 0.33884118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70995605 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86794858 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.66824569 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39514740 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36298516 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14565104 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01971745 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97460828 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.95389067 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88556085 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85387025 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78448339 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77908508 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73921538 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68471158 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68188521 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66151190 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66104490 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62069033 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.61548736 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59253141 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58382003 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55916615 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.55656789 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54151914 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53881971 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51970817 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50766454 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.47605739 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45843165 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43767335 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41610207 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40076679 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.38994516 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38545290 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.38374362 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37695964 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35607217 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34768397 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32524733 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.31079111 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30462280 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.26994255 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23537036 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23013503 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20957099 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20621009 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18438720 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15665972 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14642058 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13669316 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.13381060 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12883068 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10788045 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10413187 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09103722 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.07441168 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 1.07042739 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 1.06499088 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.06461493 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05310001 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.05082801 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03451130 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.99026018 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.98358218 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98116163 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96308948 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95062231 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94421827 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94401399 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93816310 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93311680 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92477873 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91796645 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90857830 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90049277 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89592870 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.89403104 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.89334105 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87394750 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87390594 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85554178 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85546460 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84784193 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83865703 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.83642918 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81788019 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80270170 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78359670 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76951873 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.76848131 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75682640 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75650411 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75215233 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72510244 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72075909 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71575935 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71527151 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71484695 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71319920 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.70545548 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69783495 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69624644 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68882192 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.68426764 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68067968 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66099638 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65325867 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64355098 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63600681 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63362536 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62626189 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.62619637 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61289490 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61256712 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61174011 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60955996 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59868269 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59065015 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57441808 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56535994 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56304578 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56125309 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55323720 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55142399 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55121911 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.54799157 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53979843 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53910996 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53720938 |
| 131 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53394644 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53046536 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52200476 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51626873 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51206167 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50292055 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.48574938 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47796991 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47116697 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47050360 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46122175 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45903424 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.44880049 |
| 144 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44841984 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.44612223 |
| 146 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44580113 |
| 147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44145860 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43052349 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43005260 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42668251 |
| 151 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42557850 |
| 152 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42553113 |
| 153 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42018358 |
| 154 | Focal adhesion_Homo sapiens_hsa04510 | 0.41740874 |
| 155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41731180 |
| 156 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41367456 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41299435 |
| 158 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40271090 |
| 159 | Amoebiasis_Homo sapiens_hsa05146 | 0.40134549 |
| 160 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37588048 |
| 161 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37057538 |
| 162 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36285038 |
| 163 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29525406 |
| 164 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29454017 |
| 165 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28181723 |
| 166 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28152086 |
| 167 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28074513 |
| 168 | Endocytosis_Homo sapiens_hsa04144 | 0.27224190 |
| 169 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27047193 |
| 170 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26185999 |

